ACLX FY 2022 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$191M

Net Income

-$189M

EPS (Diluted)

$-4.28

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$102M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$314M

Total Liabilities

$109M

Stockholders' Equity

$205M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	$0	—
Operating Income	-$191M	-$65M	-194.2%
Net Income	-$189M	-$65M	-190.4%